BioCentury
ARTICLE | Financial News

Achillion completes direct public offering

September 3, 2012 7:00 AM UTC

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Date completed: 8/30/12 Type: Direct public offering Raised: $41.8 million Shares: 6.4 million Price: $6.57 Shares a...